Survival outcomes in patients with oropharyngeal cancer treated with carboplatin/paclitaxel and concurrent radiotherapy.

Michael RoskiesE Kay-RivestM A MascarellaK SultanemA MlynarekM Hier

Published in: Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale (2016)

In conclusion, the overall, disease-free and locoregional recurrence-free survival of patients treated with carboplatin and radiotherapy for advanced stage OPSCC parallels what has been described in the literature for cisplatin, with an acceptable side effect profile.

Keyphrases

free survival
locally advanced
phase ii study
early stage
rectal cancer
radiation therapy
squamous cell carcinoma
papillary thyroid
radiation induced
systematic review
squamous cell
phase iii
randomized controlled trial
lymph node metastasis
open label
newly diagnosed